Gilead Announces Second Quarter 2017 Financial Results Post author:Sam Post published:July 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline Poaches Another Top Exec—This Time From Pfizer July 12, 2017 Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017 OrbiMed Comments On Immunomedics Proxy Contest February 2, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017